Wuhan Keqian Biology Co.,Ltd (SHA:688526)
China flag China · Delayed Price · Currency is CNY
12.36
-0.09 (-0.72%)
Sep 23, 2026, 3:00 PM CST

SHA:688526 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
820.82935.65933.041,027974.141,083
Other Revenue
15.4614.098.8837.1427.1219.86
836.28949.74941.921,0641,0011,103
Revenue Growth
-18.71%0.83%-11.48%6.27%-9.22%30.81%
Cost of Revenue
329.55330.72360.45321.43279.05230.42
Gross Profit
506.73619.03581.48742.65722.22872.6
Selling, General & Admin
150.78160.28169.4213.2219.26201.91
Research & Development
110.3696.4186.1288.51102.7580
Other Operating Expenses
5.661.28-0.93-0.826.295.92
Operating Expenses
261.08247.8266.47385.36339.01296.9
Operating Income
245.65371.23315.01357.29383.21575.71
Interest Expense
---4.77-8.16-5.45-1.81
Interest & Investment Income
51.7663.8373.1794.1275.6971.86
Currency Exchange Gain (Loss)
-0.28-0.8900.05--
Other Non Operating Income (Expenses)
0.831.15-0.72-0.21-0.2-0.27
EBT Excluding Unusual Items
297.96435.31382.69443.1453.25645.48
Impairment of Goodwill
---3.31---
Gain (Loss) on Sale of Investments
38.3433.2730.99-10.191.44-
Gain (Loss) on Sale of Assets
--0.93---
Asset Writedown
-1.86-1.28-0.86-1.72-0.14-1.57
Legal Settlements
-----0.82
Other Unusual Items
22.2614.2427.726.3912.0615.32
Pretax Income
356.7481.54438.13457.58466.61660.05
Income Tax Expense
44.3264.656.646257.4689.41
Earnings From Continuing Operations
312.39416.94381.49395.58409.15570.64
Minority Interest in Earnings
2.161.780.860.350.370.11
Net Income
314.55418.72382.35395.93409.52570.74
Net Income to Common
314.55418.72382.35395.93409.52570.74
Net Income Growth
-30.04%9.51%-3.43%-3.32%-28.25%27.45%
Shares Outstanding (Basic)
463465466466465464
Shares Outstanding (Diluted)
463465466466465464
Shares Change
-1.33%-0.22%0.10%0.10%0.29%20.20%
EPS (Basic)
0.680.900.820.850.881.23
EPS (Diluted)
0.680.900.820.850.881.23
EPS Growth
-29.10%9.76%-3.53%-3.41%-28.46%6.03%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
281.88344.66285.74433.53320.86156.82
Free Cash Flow Per Share
0.610.740.610.930.690.34
Dividend Per Share
0.6400.6400.4300.4300.1900.190
Dividend Growth
48.84%48.84%0%126.32%0%-34.48%
Gross Margin
60.59%65.18%61.73%69.79%72.13%79.11%
Operating Margin
29.37%39.09%33.44%33.58%38.27%52.19%
Profit Margin
37.61%44.09%40.59%37.21%40.90%51.74%
Free Cash Flow Margin
33.71%36.29%30.34%40.74%32.05%14.22%
EBITDA
363.87482.99423.23470.54480.16638.35
EBITDA Margin
43.51%50.85%44.93%44.22%47.95%57.87%
D&A For EBITDA
118.22111.76108.22113.2496.9562.64
EBIT
245.65371.23315.01357.29383.21575.71
EBIT Margin
29.37%39.09%33.44%33.58%38.27%52.19%
Effective Tax Rate
12.42%13.41%12.93%13.55%12.31%13.55%
Revenue as Reported
836.28949.74941.921,0641,0011,103
Advertising Expenses
-25.4625.734.12.872.96